Aerosol therapy for ARDS patients on ventilators
Part of Lungs & breathing clinical trials.
This trial tests whether delivering medication through a ventilator mask (aerosol therapy) can help adults with ARDS breathe better. It is designed for patients who are already on a breathing machine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with ARDS (a serious lung condition).
- You are on a mechanical ventilator (a machine that helps you breathe through a tube in your airway).
- You are 18 years or older.
- You are not using a non-invasive ventilator mask or high-flow nasal oxygen alone.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to adjust the amount of air given by the ventilator to people with a severe lung injury called ARDS. The goal is to see if a specific breathing strategy can help protect the lungs and improve recovery.
This study tests a different way of using a breathing machine (ventilator) for people with lung injury (ARDS) to see if it helps them recover better. You might be able to join if you are already on a ventilator in the ICU and meet certain health conditions.
This trial tests two types of breathing support (APRV and BiPAP) to see which works better for people with acute respiratory distress syndrome (ARDS). It may help improve breathing and recovery for those on a ventilator.
This study tests whether breathing in a mix of furosemide, heparin, and salt water (hypertonic saline) through a nebulizer can help adults with ARDS who are on a ventilator. It aims to see if these medicines can reduce lung inflammation and improve breathing.
This study looks at starting a specific type of breathing machine setting early in people with ARDS (a serious lung problem) to see if it improves outcomes. You might be able to take part if you are within 48 hours of needing a breathing tube and meet the lung oxygen criteria.
This trial tests a new way of using a ventilator (TCAV) versus standard care for people with moderate-to-severe lung failure caused by community-acquired pneumonia. It aims to see if this approach can improve outcomes.
Hear when a new ARDS (Acute Respiratory Distress Syndrome) Receiving IMV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.